Spironolactone

Treatment for Alcoholic cardiomyopathy

Typical Dosage: 12.5-25mg daily, titrated to 50mg daily

Effectiveness
70%
Safety Score
65%
Clinical Trials
1
Participants
15K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
65
DangerousModerateSafe
Treatment Details
Dosage Range
12.5-25mg daily, titrated to 50mg daily
Time to Effect
4-8 weeks
Treatment Duration
lifetime
Evidence Quality
HIGH
Number Needed to Treat (NNT)
20(Treat 20 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
15(Treat 15 patients to see 1 additional serious adverse event)
Confidence Score
85%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$80
Monitoring:$400
Side Effect Mgmt:$100
Total Annual:$580
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$10,000/QALY
QALYs Gained
0.5
Outcome-Based Costs
Cost per Responder
$1,055
Comparison vs Placebo
Cost Difference
+$580/year
More expensive
QALY Difference
+0.50 QALYs
Better outcomes
Dominance
No dominance
Spironolactone Outcomes

for Alcoholic cardiomyopathy

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+55%
Common Side Effects
Hyperkalemia
+12%
Gynecomastia
+7%
Hypotension
+5%

Sources:

iosrjournals.org
nih.gov
nih.gov

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov